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Objective. To analyze the content of outcome measures commonly used to assess health in patients with fibromyalgia
(FM) by linking the items of the instruments with the International Classification of Functioning, Disability and Health
(ICF) in order to evaluate the adequacy of currently used measures.
Methods. Questionnaires used in FM were identified in a structured literature search. All concepts included in the items
of the questionnaires were linked to ICF categories, according to previously published linking rules, by 2 independent
health professionals. The percentages of linked ICF categories addressing the different ICF components were calculated.
Results. Generic and symptom-specific instruments were included. From the 296 items contained in all 16 instruments,
447 concepts were extracted and then linked to 52 ICF categories of the component body functions, 1 category of the
component body structure, 40 categories of the component activities and participation, and 9 categories of the component
environmental factors. More than half of the concepts identified were linked to body function, fewer were linked to
activities and participation, and only concepts of 4 instruments were linked to the ICF component environmental factors.
Conclusion. Many concepts were linked to the categories in the ICF component body functions. While linking to the
broad category, purportedly similar instruments often covered widely varying areas of function at more fine-grained
levels of detail. Some categories, such as environmental factors, were barely covered by any of the instruments and might
constitute an important aspect of health deserving better coverage and future development.
INTRODUCTION
Fibromyalgia (FM) is a chronic pain condition character-
ized by widespread pain and tenderness. The American
College of Rheumatology established criteria for the clas-
sification of FM that require the following: a history of
widespread pain for at least 3 months and tenderness in at
least 11 of 18 defined tender points (1). Using this defini-
tion, 2–4% of the population in industrialized countries
satisfy the criteria for having FM (2). In clinical practice,
however, patients tend to report a more complex set of
concerns, including fatigue, sleep dysfunction, stiffness,
depression, anxiety, poor physical functioning, and cogni-
tive disturbance in addition to pain/tenderness (3,4).
The underlying pathology of FM remains poorly under-
stood, but dysfunction in central neurobiologic structures
is suspected (5,6). Actual symptom expression in FM
tends to vary on an individual basis, suggesting heteroge-
neity in the underlying mechanisms of FM and the possi-
bility of subgroups of patients with FM (3,7).
FM is best treated using dually focused interventions:
pharmacologic agents to address issues of central pain and
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nonpharmacologic approaches, e.g., aerobic exercise
and/or cognitive–behavioral therapy, to address some of
the functional consequences of pain, for instance, decon-
ditioning, poor function, and deteriorated mood (8). Sig-
nificant effort is being applied to the development of new
interventions (both pharmacologic and nonpharmaco-
logic) specifically targeting FM. To determine the efficacy
of these therapies, a variety of outcome measures have
been used to assess improvement in patients with FM, but
there has not been uniform agreement as to which domains
or which assessment tools should be utilized. Two orga-
nizations have provided some guidance in this regard. The
first, the Initiative on Methods, Measurement, and Pain
Assessment in Clinical Trials (IMMPACT), utilized the
opinions of an expert consensus panel to determine what
should be assessed in any clinical trial designed to assess
the efficacy and effectiveness of treatments for chronic
pain. This group suggested that the following outcome
domains be considered: pain, physical functioning, emo-
tional functioning, patient global ratings of satisfaction,
negative health states, adverse events, and patient adher-
ence to the treatment (9). The second group, the Outcome
Measures in Rheumatology Clinical Trials (OMERACT)
Fibromyalgia Syndrome working group, sought consensus
from both patients and clinicians regarding the relevant
outcome domains to specifically assess FM. Many of the
same domains as defined by IMMPACT were identified for
pain, but in addition, problems with sleep, cognition, ten-
derness, and stiffness were included as concerns more
specific to FM (10).
With so many domains and instruments focused on
health and functioning, clinicians and researchers can be-
come mired in confusion. Further complicating the pic-
ture, assessment instruments claiming to assess the same
domain often contain items that assess multiple domains
that can differ depending upon the instrument. These dif-
ferences between supposedly similar assessment tools are
in part due to initial vagaries in the domain definition
during instrument development.
The International Classification of Functioning, Disabil-
ity and Health (ICF) (11) classifies health and health-re-
lated status and offers a comprehensive understanding of
functioning in relation to a disease. In the ICF, functioning
is described as the complex interplay of the health com-
ponents body functions, body structures, activities and
participation, and contextual factors, such as environmen-
tal and personal factors. Activity is defined in the ICF as
the execution of a task or action by an individual, whereas
participation is the person’s involvement in a daily life
situation. Participation may therefore be considered im-
portant from the perspective of patients because it refers to
whether restrictions are experienced in daily life situa-
tions.
To date, no studies have evaluated whether the instru-
ments commonly used to assess outcomes in FM align
with the categories of function as defined by the ICF. The
outcomes of such a study could both enlighten current
instrument selection for assessing function and health in
patients with FM and inform the development of new tools
(3). Therefore, the goal of this study was to aggregate all
items of all questionnaires commonly used to assess FM
and then link the content of those items to specific ICF
codes. The intent of this process was to inform clinicians
and researchers of the specific areas of health (based on
content comparison) that are assessed when each ques-
tionnaire is administered and to help identify gaps in our
current assessment batteries used to assess the multiple
relevant domains of FM.
MATERIALS AND METHODS
Search strategy. A structured literature search was per-
formed in spring 2007. The following databases were
searched using the keywords “instrument,” “measure,”
“assessment,” “questionnaire,” “functional assessment,”
“function,” and “fibromyalgia”: CINAHL (1982–2007),
PsychINFO (1988–2007), EMBase (1988–2007), and Med-
line (1950–2007). Eligibility of the questionnaires was
checked in 3 steps. In the first step, descriptive, evaluative,
and psychometric studies were selected. Case reports, eco-
nomic evaluations, primary prevention studies, and re-
views were excluded. In the second step, studies and
articles that reported the use of functional status question-
naires were selected. In the third step, the following crite-
ria and instruments were applied: questionnaires that 1)
assessed functioning and/or health, 2) were specifically
developed for FM or were used to assess symptoms asso-
ciated with FM in studies addressing FM (e.g., depression,
fatigue), 3) were published in a peer-reviewed journal, and
4) exist in an English version.
The ICF categorization scheme. In the ICF classifica-
tion, the letters b, s, d, and e represent functional compo-
nents (i.e., body functions [b], body structures [s], activi-
ties and participation [d], and environmental factors [e]).
The components of the ICF are followed by a numeric code
starting with the chapter number (e.g., Chapter 6: Domestic
Life; 1 digit), followed by the second level (2 digits) and
the third and fourth levels (1 digit each). For example,
coding “diminished sleep” might use the following coding
scheme: the letter (component) would be body functions
(b) and would be followed by the digit 1 representing
Chapter 1 (Mental Functions) and would thus result in the
first-level code b1 mental functions. The second-level code
would be b134 sleep functions and the third-level code,
b1340 amount of sleep. The fourth level is not available in
this case. At the end of each chapter, there are other
specified categories (uniquely identified by the final code
8) and unspecified categories (uniquely identified by the
final code 9).
Linking to the ICF codes. Linking rules have been de-
veloped to link functioning instruments to the ICF in a
specific and precise manner (12,13). Based on these link-
ing rules, each item of an instrument should be linked to
the ICF category that most precisely represents the item’s
content. An item of a questionnaire can include more than
1 concept, thus the first step of the analysis was to identify
the concepts in each item. A concept was defined as 1
separate meaningful entity, such as a body structure, a
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body function, an activity, or a contextual factor. Table 1
shows the linking of the items of the Fibromyalgia Impact
Questionnaire (FIQ) to the appropriate categories of the
ICF, e.g., item 14 of the FIQ: “When you worked, how
much did pain or other symptoms of your fibromyalgia
interfere with your ability to do your work, including
housework?” In this item, the following 4 concepts were
identified: 1) “pain,” 2) “other symptoms of your fibromy-
algia,” 3) “work,” and 4) “housework.” The 4 concepts
were linked to the following ICF categories: b280 sensation
of pain, d640 doing housework, d850 remunerative em-
ployment, and hc (health condition). For the purpose of
this study, a meaningful concept that referred to a diagno-
sis or a health condition, such as “symptoms of your
fibromyalgia,” was assigned to hc.
If the content of a concept was more general than the
corresponding ICF category, the code of the higher level
was linked. An example is the concept “I have to limit my
social activity” from the Functional Assessment of
Chronic Illness Therapy–Fatigue Scale (FACIT-FS), which
was linked to Chapter 9: Community, Social and Civic Life
because “my social activity” is more general than the avail-
able second-level categories in this chapter. A concept that
was considered as not being contained in the ICF classifi-
cation was assigned as not covered, for instance, the con-
cept “attempts at suicides” of the Hamilton Rating Scale
for Depression (HRSD). Furthermore, if the information
about a concept was not sufficient to make a decision
about the most appropriate ICF category, the concept was
linked to not definable, such as “I am forced to spend time
in bed,” a concept of the fatigue-assessment questionnaire
FACIT-F.
The linking process was carried out by 2 health profes-
sionals according to the description or definition of the
item of the instrument in the literature. The number of
concepts identified in each questionnaire and the ICF cat-
egories linked were reported both in total and separated by
component.
Table 1. Linking of the items of the Fibromyalgia Impact Questionnaire (FIQ) to the ICF*
FIQ item Concept ICF category
1. Were you able to do shopping? To shop d6200 Shopping
2. Were you able to do laundry
with a washer and dryer?
To do laundry d6403 Using household appliances
3. Were you able to prepare meals? To prepare meal d630 Preparing meals
4. Were you able to wash dishes/
cooking utensils by hand?
To wash the dishes d6401 Cleaning cooking area and
utensils
5. Were you able to vacuum a rug? To vacuum a rug d6403 Using household appliances
6. Were you able to make beds? To make beds d640 Doing housework
7. Were you able to walk several
blocks?
To walk d4501 Walking long distances
8. Were you able to visit friends or
relatives?
To visit friends/relatives d9205 Socializing
9. Were you able to do yard work? To do yard work d6505 Taking care of plants,
indoors and outdoors
10. Were you able to drive a car? To drive a car d4751 Driving motorized vehicles
11. Were you able to climb stairs? To climb stairs d4551 Climbing
12. Of the 7 days in the past week,
how many days did you feel
good?
To feel good pf
13. How many days last week did









14. When you worked, how much
did pain or other symptoms of
your fibromyalgia interfere with











15. How bad has your pain been? Pain b280 Sensation of pain
16. How tired have you been? To be tired b1300 Energy level
17. How have you felt when you get
up in the morning?
Feeling when getting up in
the morning
b1343 Quality of sleep
18. How bad has your stiffness
been?
Stiffness b7800 Sensation of muscle stiffness





b1522 Range of emotion
20. How depressed or blue have
you felt?
To feel depressed or blue b152 Emotional functions
* Every item of the instrument was linked to the appropriate ICF category. ICF  International Classification of Functioning, Disability and Health; pf 
personal factor; hc  health condition.
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Rater interreliability. Consensus between 2 health pro-
fessionals (Edda Amann and Barbara Kollerits) was used to
determine which concepts were identified in all items of
the questionnaires and which ICF category should be
linked to each concept. In the case of disagreement be-
tween the 2 health professionals, a third person trained in
the linking rules was consulted. In a discussion led by the
third person (AC), the 2 health professionals that linked
the concept stated pros and cons for the identification of a
concept and for linking this concept to a specific ICF
category. Based on these statements, the third person made
an informed decision.
The degree of agreement between the 2 health profes-
sionals regarding the identified and linked concepts was
calculated by means of the kappa statistic (14). Kappa
values generally range from 0 to 1, where 1 indicates
perfect agreement and 0 indicates no additional agreement
beyond what is expected by chance alone. A kappa coef-
ficient 0.61 was regarded as good or acceptable for this
study (15). The statistical analysis was performed with
SPSS 12.0.1 (SPSS, Chicago, IL).
RESULTS
Literature search. In step 1, the literature search pro-
duced 284 hits in CINAHL, 52 in PsychINFO, 547 in
EMBase, and 661 in Medline. In the second step, the
selection criteria for the articles were applied and 24 arti-
cles and 5 abstracts were reviewed in detail. In the third
step, 16 questionnaires were identified according to the
selection criteria and included in the analysis and are
Table 2. Questionnaires included in the analysis
Instrument (reference)
Fibromyalgia specific
Fibromyalgia Impact Questionnaire (FIQ) (18)
Pain
McGill Pain Questionnaire (MPQ) (19)
Short Form McGill Pain Questionnaire (SF-MPQ) (20)
Brief Pain Inventory (BPI) (21)
Leeds Assessment of Neuropathic Symptoms and
Signs Pain Scale (LANSS) (22)
Fatigue
Functional Assessment of Chronic Illness Therapy
(FACIT-FS) (30)
Functional Assessment of Chronic Illness Therapy–
Fatigue (FACIT-F) (30)
Fatigue Severity Scale (FSS) (31)
Multidimensional Fatigue Inventory (MFI) (32)
Multidimensional Assessment of Fatigue (MAF) (33,40)
Sleep
Sleep scale from Medical Outcomes Study (MOS) (26)
General health
Short Form 36 Health Survey (SF-36) (36,37)
Sexuality
Arizona Sexual Experiences Scale (ASEX) (34)
Depression
Beck Depression Inventory (BDI) (38)
Hospital Anxiety and Depression Scale (HADS) (10)



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































Content Comparison of FM Instruments Based on the ICF 653
Table 4. International Classification of Functioning, Disability and Health (ICF) categories covered by each instrument*










36 ASEX BDI HADS HRSD
Body functions
b1100 State of consciousness 1
b1261 Agreeableness 1
b1263 Psychic stability 1 1
b1265 Optimism 1 3
b1266 Confidence 3
b130 Energy and drive function 6 1
b1300 Energy level 1 11 11 8 6 2 3 1 1 2
b1301 Motivation 1 1
b1302 Appetite 1 1
b134 Sleep functions 1 1
b1340 Amount of sleep 2
b1341 Onset of sleep 3 2
b1342 Maintenance of sleep 2 3
b1343 Quality of sleep 1 1 2 1
b140 Attention functions 3
b1400 Sustaining attention 1
b1470 Psychomotor control 1 1 1 5
b152 Emotional functions 1 1 1 8 1 1 8 2 7 5
b1522 Range of emotion 1 1 1 2 4
b1600 Pace of thought 1
b1602 Content of thought 1 1 10
b1603 Control of thought 1
b1644 Insight 1
b1800 Experience of self 2
b1801 Body image 1 1
b2702 Sensitivity to pressure 1
b280 Sensation of pain 2 4 18 14 3 1 2
b2801 Pain in body part 2
b28010 Pain in head and neck 2 2 1 1
Body functions
b28012 Pain in stomach or
abdomen
1
b28013 Pain in back 1
b3302 Speed of speech 1
b410 Heart functions 1




b4550 General physical endurance 2
b4552 Fatiguability 1 6 1




b515 Digestive functions 3





b535 Sensations associated with
the digestive system
1
b5350 Sensations of nausea 1
b620 Urination functions 1
b640 Sexual functions 2 1
b6400 Functions of sexual arousal
phase
1 1
b6402 Functions of orgasmic
phase
1
b6403 Functions of sexual
resolution phase
1




b7800 Sensation of muscle
stiffness
1
b840 Sensation related to skin 2
Body structure
s810 Structure of areas of skin 1
Activities and participation
d177 Making decisions 1 2
d2200 Carrying out multiple tasks 1 1
(continued)
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Table 4. International Classification of Functioning, Disability and Health (ICF) categories covered by each instrument*
(Continued)










36 ASEX BDI HADS HRSD
d2201 Completing multiple tasks 1 1
d230 Carrying out daily routine 2 2 1 3 2
d4102 Kneeling 1
d4105 Bending 2
d4154 Maintaining a standing position 1
d430 Lifting and carrying objects 1
d4300 Lifting 1 1
d4450 Pulling 1
d450 Walking 2 1
d4500 Walking short distances 1
d4501 Walking long distances 1 2
d4551 Climbing 1 2
d4552 Running 1
d4751 Driving motorized vehicles 1
d510 Washing oneself 1
d5101 Washing whole body 1
d540 Dressing 1 1
d550 Eating 1 1
d620 Acquisition of goods and services 1
d6200 Shopping 1
d630 Preparing meals 1 1
d640 Doing housework 3 1 2 1 1
d6401 Cleaning cooking area and
utensils
1
d6403 Using household appliances 2 1
d6505 Taking care of plants, indoors
and outdoors
1
d7 Interpersonal interactions and
relationship
1 1 1
d750 Informal social relationship 1
d7500 Informal relationships with
friends
1 1
d7501 Informal relationships with
neighbors
1
d760 Family relationships 3 1 1
d770 Intimate relationships 1
d7702 Sexual relationships 1 1
d850 Remunerative employment 2 1 2 1 3 1 3
d9 Community, social, and civic life 1 1 1 1 1
d920 Recreation and leisure 1 1 1
d9201 Sports 1 3
d9204 Hobbies 1
d9205 Socializing 1 1 1
Environmental factors
e1101 Drugs 5
e1150 General products—for personal
use in daily living
1
e1151 Assistive products—for personal
use in daily living
2
e3 Supports and relationships 1 1
e310 Immediate family 1 1
e315 Extended family
e320 Friends 1 1
e410 Individual attitudes of immediate
family members
1
e5800 Health services 3
Not covered 2
Personal factor 1 3 1 3 3 1
Personal factor-subjective 1
Health condition 2 1 7
Not definable 1 3 7 2 6
Not definable health condition 3 1 1
Not definable activities and participation 2 1 1 2 1 2
Not definable general health 1 4 1
Not definable quality of life 1
Not definable physical health 3
Not definable body function 1
* This table shows the linking of the concepts contained in the items of the instruments using the ICF categories as a reference and ordered by
component. Values are the frequencies with which the ICF categories were found to be addressed in the different instruments. A higher number
indicates that several concepts from a specific instrument were linked to the same ICF category. See Table 2 for definitions.
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listed in Table 2. Tools currently used are FM specific and
symptom specific. The number of items of each question-
naire is presented in Table 3. The FIQ was the only FM-
specific instrument in this literature search. Because psy-
chiatric symptoms may influence pain and dysfunction as
well as provide a sense of the impact of pain, fatigue, and
other symptoms, assessments of depression were included
(10).
Instrument item linkage to ICF codes. The linking of
the concepts contained in the items of the instruments
using the ICF categories as a reference and ordered by
components is shown in Table 4 (a–d). The numbers in the
table represent the frequencies with which the ICF catego-
ries were addressed in the different instruments. A higher
number indicates that several concepts from a specific
instrument were linked to the same ICF category. For
example, the category d760 family relationship was linked
to the following 3 concepts of the FACIT-F: “having trou-
bles to meet the needs of the family,” “family well-being,”
and “satisfaction with family communication about ill-
ness.”
In 296 items of all instruments, 447 concepts were iden-
tified, which were then linked to 52 ICF categories of the
component body functions, 1 category of the component
body structure, 40 categories of the component activities
and participation, 9 categories of the component environ-
mental factors, and 13 concepts to personal factors (Table
4 [a–d]). Ten concepts were considered to be related to
health condition and were not linked to any ICF category.
Forty-four concepts were not definable, and the following
2 concepts were found to be not covered by the ICF:
suicides and attempts at suicides (concept in item 3 of the
HRSD).
The frequencies of items and concepts of the instru-
ments and ICF categories in relation to each other are
shown in Table 3. The total number of the ICF categories
linked to the concepts of the questionnaires shows remark-
able differences. While some instruments showed a con-
siderable diversity in their content (such as the Short Form
36 [SF-36], which includes 36 items from which 57 con-
cepts were extracted and linked to 44 ICF categories), other
instruments were linked to few or only 1 ICF category
(such as the Arizona Sexual Experience Scale [ASEX],
which includes 5 items from which 5 concepts were ex-
tracted and linked to 5 ICF categories).
The kappa statistic for agreement between the 2 inves-
tigators was 0.74 (P  0.0001). The kappa coefficient ex-
ceeded 0.61 and thus was regarded as good.
DISCUSSION
For clinicians and researchers who wish to select an in-
strument for measuring a specific end point, it is important
to know which domains are covered by which instruments
and which areas receive no coverage at all. The findings of
this study suggest that many areas of health are covered by
the most commonly used measures, and that each instru-
ment differs in the breadth of content that items cover.
One-third of the items of the FIQ, the only FM-specific
instrument, were linked to body functions and two-thirds
were linked to activities and participation. The remaining
concepts were linked to health condition or personal fac-
tor, such as the item “How many days last week did you
miss work, including housework, because of fibromyal-
gia?” in which the meaningful concept “because of fibro-
myalgia” was linked to health condition. This instrument
clearly links to health condition itself and is therefore not
etiologically neutral (16). Because a lack of a clinical basis
by which FM might be identified as a separate entity is
evident (17), one might argue whether it is possible to have
a special instrument in FM or whether a special instru-
ment is required at all. Although it would be desirable for
daily clinical practice to have 1 instrument covering the
diversity of symptoms in FM, this might raise psychomet-
ric difficulties such as insensitivity associated with the
multidimensionality, and differential item functioning as-
sociated with sex, as occurred in the FIQ (18).
Regarding the 4 instruments used to assess pain (McGill
Pain Questionnaire [MPQ], Short Form MPQ [SF-MPQ],
Brief Pain Inventory [BPI], and Leeds Assessment of Neu-
ropathic Symptoms and Signs Pain Scale [LANSS]
[19–22]), considerable differences occurred in the ICF
components covered. While the SF-MPQ was linked to
body functions only, the MPQ and LANSS covered mainly
body functions, and the BPI showed more diversity and
was linked to body functions, activities and participation,
and environmental factors. When assessing pain, the as-
sessor must choose the instrument based upon what
knowledge is desired (i.e., whether pain is affecting body
function or activities and participation). In the literature,
pain is described as both a symptom and a contributor to
other symptoms such as fatigue, impairment of concentra-
tion, negative mood, degraded sleep, and diminished over-
all activity (9). Although it is evident that environmental
factors have an impact on functioning in daily life from the
perspective of patients (23–25), not all of the pain assess-
ment instruments addressed these factors.
The Medical Outcomes Study sleeping scale (26) was
only linked to body functions and the majority of concepts
were linked to the ICF category b134 sleep functions.
Many people with FM report sleep disturbances. Sleep
impacts pain, fatigue, and social functioning (27,28); nev-
ertheless, it is not clearly stated whether sleep disturbance
is a symptom occurring itself or as a comorbidity. The
relationship between sleep and pain was investigated by
Affleck et al (29), who stated that the relationship might be
bidirectional, meaning that pain might increase distur-
bance in sleep, and disturbed sleep could intensify pain,
or even both. Sleep is rarely included in multidimensional
assessment instruments; 2 exceptions are the BPI for as-
sessing pain and the HRSD for depression, which include
aspects of sleep. However, it might be recommended to
assess sleep and pain in patients with FM.
Less than half of the concepts extracted from the fatigue-
specific instruments (FACIT-FS, FACIT-F, Fatigue Sever-
ity Scale, Multidimensional Fatigue Inventory, Multidi-
mensional Assessment of Fatigue [MAF] [30–33]) were
linked to body functions. Activities and participation was
covered by all fatigue instruments, whereas environmental
factors only occurred in the FACIT-FS, the FACIT-F, and
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the MAF. Coverage of fatigue in FM was considered by
patients to be the second most important domain after pain
(10), which is consistent with the relative importance of
fatigue in the deterioration of activities and participation
in other rheumatic diseases of long duration in general
(24,33). As with pain, the relative lack of emphasis on
environmental factors in the existing instruments assess-
ing fatigue may indicate a gap that deserves future devel-
opment.
The ASEX, an instrument that assesses sexual function,
was only linked to body functions. The assessment of
sexual function was considered important both as a do-
main of human function and because of the potential for
adverse effects of medications on sexual function in pa-
tients with FM. Female patients with FM have distinct
issues associated with sexual function compared with
healthy controls (34). Tikiz et al (35) highlighted that the
impact of FM on sexual function can be profound in ad-
dition to limiting one’s ability to perform other essential
life tasks and social roles. Sexual dysfunction may also
cause significant personal distress and negatively impacts
quality of life. In the ASEX, sexual function is assessed
solely in the ICF component body functions. This has to be
considered because assessing the dysfunction itself does
not allow drawing any conclusions about the subjective
meaning or choice of sexual function and thus the indi-
vidual impact on quality of life.
The SF-36 (36,37) and the 3 depression instruments
(Beck Depression Inventory, Hospital Anxiety and Depres-
sion Scale, HRSD [38]) were linked to body function as
well as activities and participation. Because the impact of
the syndrome profoundly influences the patient’s normal
life and daily activity pattern in work, home maintenance,
and leisure activities (39), assessing concepts related to the
component activities and participation in FM should be
highlighted.
Visual analog scales for pain, fatigue, and disease activ-
ity or global health status are, per definition, self-report
instruments. However, because they can be linked to a
single ICF category only (b280 pain, b130 energy and drive
functions) or to the health condition itself, they were not
included in this analysis, which focused on a comparison
of the content of instruments. Further research should
focus on the psychometric properties of instruments and
may suggest how to best measure specific concepts or
categories. In terms of content, instruments that measure
pain and fatigue not only within the ICF component body
functions, but also within activities and participation may
be preferable, as has been argued above.
The content of the questionnaires assessing health in
patients with FM differs considerably, not the least due to
the multidimensional nature of FM. Several instruments
are available to assess pain, fatigue, and depression. All of
them cover categories of the ICF concept body function,
but not all could be linked to concepts regarding activities
and participation and environmental factors. Thus, when
selecting an instrument, careful consideration needs to be
taken into account regarding which aspects of health
should be covered. Based on the comparison made in this
article, researchers and clinicians should be able to make a
more informed decision about which questionnaires best
cover the content of the end points they wish to assess.
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